Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Clinical trial NCT07011719 · RECRUITING

Trial details

NCT number: NCT07011719
Sponsor: Arcus Biosciences, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Clear Cell Renal Cell Carcinoma Advanced Clear Cell Renal Cell Carcinoma

Start date: 2025-09-08
Primary completion: 2028-04-01
Enrollment: 720

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.